Skip to content
Combined Shape Created with Sketch.
  • COVID-19
  • EyewireTV
  • Stocks
  • Interests
    • Cataract and Refractive Eye-Grey Created with Sketch.
    • Glaucoma Gauge-Grey Created with Sketch.
    • Healthcare Cross-Grey Created with Sketch.
    • Optometry Laser-Grey Created with Sketch.
    • Product Approvals Gear-Grey Created with Sketch.
    • Retina Laser-Grey Created with Sketch.
  • More
    • Events
    • Subscribe
    • About
    • Send a Tip
    • Advertising
    • Privacy Policy
  • COVID-19
  • EyewireTV
  • Stocks
  • Interests
    • Cataract and Refractive Eye-Grey Created with Sketch.
    • Glaucoma Gauge-Grey Created with Sketch.
    • Healthcare Cross-Grey Created with Sketch.
    • Optometry Laser-Grey Created with Sketch.
    • Product Approvals Gear-Grey Created with Sketch.
    • Retina Laser-Grey Created with Sketch.
  • Events
  • About
  • Send a Tip
  • Advertising
  • Privacy Policy

AstraZeneca

01.13.21

EMA Receives Conditional Marketing Request for AstraZeneca’s COVID-19 Vaccine

Source: FirstWord

11.30.20

UK Government Asks Regulator to Clear “Temporary Supply” of AstraZeneca’s COVID-19 Vaccine

Source: FirstWord

11.23.20

AstraZeneca Says COVID-19 Vaccine Candidate Shows 70% Efficacy

Source: FirstWord

11.20.20

Data Confirm Immune Response From AstraZeneca’s COVID-19 Vaccine in Elderly

Source: FirstWord

11.13.20

AstraZeneca’s Calquence Fails to Help Patients Hospitalized With COVID-19 Respiratory Symptoms

Source: FirstWord

10.27.20

AstraZeneca’s COVID-19 Vaccine Produces Robust Immune Response in Elderly

Source: FirstWord

10.26.20

AstraZeneca, J&J Say Their COVID-19 Vaccine Trials Back on Track in US

Source: FirstWord

10.22.20

Suspected Control Group Participant in AstraZeneca COVID-19 Vaccine Study Dies; Trial Continues

Source: FirstWord

10.21.20

Sources Say US Study of AstraZeneca’s COVID-19 Vaccine May Restart This Week

Source: FirstWord

10.12.20

AstraZeneca to Test Long-Acting Antibody Treatment AZD7442 in COVID-19 Trials

Source: FirstWord

View more stories

Home

Menu

Share

  • Cataract and Refractive
  • Cornea
  • Glaucoma
  • Healthcare
  • Innovation
  • Optometry
  • Product Approvals
  • Retina
  • Events
  • About
  • Send a Tip
  • Advertising
  • Contact
  • EyewireTV
  • Stocks
  • Privacy Policy
Created with Sketch. Created with Sketch. Created with Sketch. Created with Sketch.
eyewire-news-color bmc-mark Created with Sketch.

© 2021 Bryn Mawr Communications, LLC.

All Rights Reserved.